CHEBI:231350 - pacritinib

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name pacritinib
ChEBI ID CHEBI:231350
Definition An azamacrocycle with formula C28H32N4O3. It is a Janus kinase inhibitor and its citrate salt is approved for the treatment of intermediate or high risk, primary or secondary myelofibrosis.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Delphine Zhou
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C28H32N4O3
Net Charge 0
Average Mass 472.589
Monoisotopic Mass 472.24744
InChI InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+
InChIKey HWXVIOGONBBTBY-ONEGZZNKSA-N
SMILES C(CN1CCCC1)OC1=C2COC\C=C\COCC3=CC=CC(=C3)C3=CC=NC(NC(C=C1)=C2)=N3
Roles Classification
Biological Role(s): EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that specifically blocks the action of non-specific protein-tyrosine kinase (EC 2.7.10.2).
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing pacritinib (CHEBI:231350) has role anti-inflammatory agent (CHEBI:67079)
pacritinib (CHEBI:231350) has role antineoplastic agent (CHEBI:35610)
pacritinib (CHEBI:231350) has role apoptosis inducer (CHEBI:68495)
pacritinib (CHEBI:231350) has role EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor (CHEBI:76617)
pacritinib (CHEBI:231350) is a azamacrocycle (CHEBI:52898)
pacritinib (CHEBI:231350) is a benzenes (CHEBI:22712)
pacritinib (CHEBI:231350) is a cyclic ether (CHEBI:37407)
pacritinib (CHEBI:231350) is a pyrrolidines (CHEBI:38260)
pacritinib (CHEBI:231350) is conjugate base of pacritinib(1+) (CHEBI:231411)
Incoming pacritinib(1+) (CHEBI:231411) is conjugate acid of pacritinib (CHEBI:231350)
IUPAC Name
(16E)-11-[2-(pyrrolidin-1-yl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8(26),9,11,16,21,23-decaene
INNs Sources
pacritinib WHO MedNet
pacritinib WHO MedNet
pacritinib WHO MedNet
pacritinibum WHO MedNet
Synonyms Sources
(16E)-11-[2-(1-pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene ChEBI
SB 1518 DrugBank
SB-1518 DrugBank
SB1518 DrugBank
Manual Xrefs Databases
6T3 PDBeChem
D11768 KEGG DRUG
DB11697 DrugBank
Pacritinib Wikipedia
View more database links
Registry Number Type Source
937272-79-2 CAS Registry Number KEGG DRUG
Citations Waiting for Citations Types Sources
21604762 PubMed citation Europe PMC
25170285 PubMed citation Europe PMC
27598824 PubMed citation Europe PMC
29191878 PubMed citation Europe PMC
34551507 PubMed citation Europe PMC
35489775 PubMed citation Europe PMC
35567653 PubMed citation Europe PMC
35622972 PubMed citation Europe PMC
35877951 PubMed citation Europe PMC
35983661 PubMed citation Europe PMC
35993369 PubMed citation Europe PMC
36467816 PubMed citation Europe PMC
36469321 PubMed citation Europe PMC
36601980 PubMed citation Europe PMC
36651066 PubMed citation Europe PMC
36697489 PubMed citation Europe PMC
36822800 PubMed citation Europe PMC
36861402 PubMed citation Europe PMC
36922391 PubMed citation Europe PMC
36959157 PubMed citation Europe PMC
37203407 PubMed citation Europe PMC
37427653 PubMed citation Europe PMC
37552106 PubMed citation Europe PMC
37916436 PubMed citation Europe PMC
38164985 PubMed citation Europe PMC
38201581 PubMed citation Europe PMC
38295318 PubMed citation Europe PMC
38374336 PubMed citation Europe PMC
38562076 PubMed citation Europe PMC
38646919 PubMed citation Europe PMC
Last Modified
10 May 2024